IFNB1 and myeloid sarcoma: Among DMTs, GA and IFN-b1 were associated with a 50% increase risk of overall serious infections (defined as an infection resulting in hospitalization) in MS patients in comparison to that seen from age-/sex-matched non-MS patients [43].